课题基金 / 基金详情

The circadian clock protein BMAL and post-translational regulation of ENaC in the kidney

The circadian clock protein BMAL and post-translational regulation of ENaC in the kidney
肾脏中生物钟蛋白 BMAL 和 ENaC 的翻译后调节
批准号:
10662317
负责人:
Abdel Ayube Alli
金额:
$33.55万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-07-01 至 2025-06-30

项目摘要

项目成果

Abdel Ayube Alli的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT The epithelial sodium channel (ENaC) expressed in the distal tubule and collecting duct is responsible for the final regulation of sodium reabsorption by the kidneys. The myristoylated alanine-rich C kinase substrate (MARCKS) plays an important role as an adaptor protein between the anionic phospholipid PIP2 and ENaC. Both ENaC and MARCKS are positively regulated by the protease cathepsin B. First, our preliminary data demonstrate renal ENaC activity and MARCKS protein expression are positively regulated by the circadian protein BMAL1. Second, our preliminary data show alpha-1 antitrypsin is increased in the BMAL1 knockout mouse kidney compared to the kidney of wild-type mice sacrificed at the same time. Third, our preliminary data show alpha-1 antitrypsin is expressed in the kidney and it strongly inhibits cathepsin B activity and contributes to blood pressure regulation. In this project we will test our hypothesis that the association between renal ENaC and MARCKS, and their function at the apical plasma membrane negatively correlates with alpha-1 antitrypsin expression in a circadian dependent manner. We will perform experiments to investigate proteolysis and apical membrane expression of ENaC and MARCKS, ENaC activity, sodium handling, and blood pressure using male and female BMAL1 knockout mice, alpha-1 antitrypsin knockout mice, alpha-1 antitrypsin overexpressing mice, cathepsin B knockout mice, and wild-type control mice. The successful completion of our proposed studies for this project will reveal new mechanisms underlying the role of BMAL1 in the regulation of renal ENaC and MARCKS and blood pressure control. Our long term goal is to provide a better understanding for the pathogenesis of essential hypertension that can potentially lead to novel drug targets and therapeutics.
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
DOI: 10.3390/biomedicines11020305
发表时间: 2023-01-21
期刊: Biomedicines
影响因子: 4.7
作者: []
通讯作者:
DOI: 10.3390/biom13010066
发表时间: 2022-12-29
期刊: Biomolecules
影响因子: 5.5
作者: []
通讯作者:
DOI: 10.3389/fphys.2021.710313
发表时间: 2021
期刊: Frontiers in physiology
影响因子: 4
作者: [Liu LP, Gholam MF, Elshikha AS, Kawakibi T, Elmoujahid N, Moussa HH, Song S, Alli AA]
通讯作者: Alli AA
Tempol treatment normalizes membrane expression of epithelial transport proteins in the kidney of salt-loaded hypertensive diabetic db/db mice.
Tempol 治疗可使盐负荷高血压糖尿病 db/db 小鼠肾脏中上皮转运蛋白的膜表达正常化。
DOI: --
发表时间: 2023
期刊: American journal of translational research
影响因子: 2.2
作者: [Dogan,YunusE, Bala,Niharika, Chacko,KevinM, Tuna,KubraM, Alli,AbdelA]
通讯作者: Alli,AbdelA
12
    The circadian clock protein BMAL and post-translational regulation of ENaC in the kidney
    • 批准号:
      10202590
    • 项目类别:
    • 资助金额:
      $33.55万
    • 财政年份:
      2020
    • 负责人:
      Abdel Ayube Alli
    • 依托单位:
    The circadian clock protein BMAL and post-translational regulation of ENaC in the kidney
    • 批准号:
      10440278
    • 项目类别:
    • 资助金额:
      $33.55万
    • 财政年份:
      2020
    • 负责人:
      Abdel Ayube Alli
    • 依托单位:
    Calicum, MARCKS, and PIP2 regulation of ENaC
    • 批准号:
      8700958
    • 项目类别:
    • 资助金额:
      $13.37万
    • 财政年份:
      2014
    • 负责人:
      Abdel Ayube Alli
    • 依托单位:
    Calicum, MARCKS, and PIP2 regulation of ENaC
    • 批准号:
      9283532
    • 项目类别:
    • 资助金额:
      $13.94万
    • 财政年份:
      2014
    • 负责人:
      Abdel Ayube Alli
    • 依托单位: